These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34044125)
21. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA. Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438 [TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632 [TBL] [Abstract][Full Text] [Related]
23. The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update. Mahoney-Sanchez L; Belaidi AA; Bush AI; Ayton S J Mol Neurosci; 2016 Nov; 60(3):325-335. PubMed ID: 27647307 [TBL] [Abstract][Full Text] [Related]
24. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice. Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217 [TBL] [Abstract][Full Text] [Related]
25. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice. Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680 [TBL] [Abstract][Full Text] [Related]
26. Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention. Keeney JT; Ibrahimi S; Zhao L J Alzheimers Dis; 2015; 48(2):411-24. PubMed ID: 26402005 [TBL] [Abstract][Full Text] [Related]
27. The Interplay of Apoes with Syndecans in Influencing Key Cellular Events of Amyloid Pathology. Hudák A; Jósvay K; Domonkos I; Letoha A; Szilák L; Letoha T Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209175 [TBL] [Abstract][Full Text] [Related]
28. Reduced binding of apoE4 to complement factor H promotes amyloid-β oligomerization and neuroinflammation. Chernyaeva L; Ratti G; Teirilä L; Fudo S; Rankka U; Pelkonen A; Korhonen P; Leskinen K; Keskitalo S; Salokas K; Gkolfinopoulou C; Crompton KE; Javanainen M; Happonen L; Varjosalo M; Malm T; Leinonen V; Chroni A; Saavalainen P; Meri S; Kajander T; Wollman AJ; Nissilä E; Haapasalo K EMBO Rep; 2023 Jul; 24(7):e56467. PubMed ID: 37155564 [TBL] [Abstract][Full Text] [Related]
29. Roles of ApoE4 on the Pathogenesis in Alzheimer's Disease and the Potential Therapeutic Approaches. Sun YY; Wang Z; Huang HC Cell Mol Neurobiol; 2023 Oct; 43(7):3115-3136. PubMed ID: 37227619 [TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan. Fu Y; Zhao J; Atagi Y; Nielsen HM; Liu CC; Zheng H; Shinohara M; Kanekiyo T; Bu G Mol Neurodegener; 2016 May; 11(1):37. PubMed ID: 27151330 [TBL] [Abstract][Full Text] [Related]
32. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340 [TBL] [Abstract][Full Text] [Related]
33. APOE effects on regional tau in preclinical Alzheimer's disease. Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ; Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122 [TBL] [Abstract][Full Text] [Related]
34. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1. Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718 [TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism. Poirier J Ann N Y Acad Sci; 2000; 924():81-90. PubMed ID: 11193807 [TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein (apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: apoE structure as a potential therapeutic target. Ye S; Huang Y; Müllendorff K; Dong L; Giedt G; Meng EC; Cohen FE; Kuntz ID; Weisgraber KH; Mahley RW Proc Natl Acad Sci U S A; 2005 Dec; 102(51):18700-5. PubMed ID: 16344478 [TBL] [Abstract][Full Text] [Related]
37. A flow cytometry-based Kara E; Marks JD; Roe AD; Commins C; Fan Z; Calvo-Rodriguez M; Wegmann S; Hudry E; Hyman BT J Biol Chem; 2018 Aug; 293(34):13247-13256. PubMed ID: 29950521 [TBL] [Abstract][Full Text] [Related]
38. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. Youmans KL; Tai LM; Nwabuisi-Heath E; Jungbauer L; Kanekiyo T; Gan M; Kim J; Eimer WA; Estus S; Rebeck GW; Weeber EJ; Bu G; Yu C; Ladu MJ J Biol Chem; 2012 Dec; 287(50):41774-86. PubMed ID: 23060451 [TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease. Dorey E; Chang N; Liu QY; Yang Z; Zhang W Neurosci Bull; 2014 Apr; 30(2):317-30. PubMed ID: 24652457 [TBL] [Abstract][Full Text] [Related]
40. Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-Aβ interaction and Aβ fibrillation. Moon HJ; Haroutunian V; Zhao L Neurobiol Dis; 2022 Mar; 164():105631. PubMed ID: 35041991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]